Yonsei Med J.  2009 Oct;50(5):617-623. 10.3349/ymj.2009.50.5.617.

Celiac Disease: Presentation of 109 Children

Affiliations
  • 1Dapartment of Pediatric Gastroenterology, Ankara University, School of Medicine, Ankara, Turkey. zarifekuloglu@yahoo.com
  • 2Dapartment of Pathology, Ankara University, School of Medicine, Ankara, Turkey.

Abstract

PURPOSE
The clinical features of patients with celiac disease (CD) are variable. In the present study, clinical and laboratory features of 109 patients with CD were retrospectively evaluated. MATERIALS AND METHODS: In all cases, diagnosis of CD was made by European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) criteria and clinical and laboratory findings, including hematological and biochemical analyses, immunoglobulin levels, autoantibodies [antinucler antibody (ANA), antidouble stranded DNA (dsDNA), antimitochondrial antibody (AMA), anti-smooth muscle antibody (ASMA), liver kidney antibody (LKM-1), anti thyroid peroxidase (TPO), anti thyroglobulin (Tg)], bone mineral density (BMD), and electroencephalogram were evaluated. The type of CD was recorded. RESULTS: Of 109 patients with CD, 66 (60.6%) were classical type, 41 (37.6%) were atypical type and 2 (1.8%) were silent type. The mean age was 8.81 +/- 4.63 years and the most common symptom was diarrhea (53.2%) followed by failure to thrive, short stature, and abdominal pain. Paleness (40.4%), underweight (34.8%), and short stature (31.2%) were the most common findings. Iron deficinecy anemia (81.6%), zinc deficiency (64.1%), prolonged prothrombin time (35.8%), and elevated transaminase levels (24.7%) were the most common laboratory findings. Eight percent of patients had at least 1 autoantibody, and 28 of 52 patients had low BMD. Four of 38 patients had abnormalty in electroencephalograms. The prevalance of selective immunoglobulin (Ig) A deficiency was 9.1%. Histocompatibility antigen HLA-DQ and/or DQ8 genotypes were found in 91% of patients. Abdominal distention, iron deficiency, prolonged prothrombine time, hypoalbuminemia, and elevated transaminase levels were more significantly frequent in the classical type than atypical type (p < 0.005). CONCLUSION: Although classical CD was seen in most patients in the present study, clinical variability of the condition should be kept in mind.

Keyword

Celiac disease; children

MeSH Terms

Adolescent
Celiac Disease/*diagnosis
Child
Child, Preschool
Female
Humans
Infant
Male
Retrospective Studies
Turkey

Cited by  1 articles

Comparison of Endoscopic and Histological Findings between Typical and Atypical Celiac Disease in Children
Pooja Semwal, Raj Kumar Gupta, Rahul Sharma, Kapil Garg
Pediatr Gastroenterol Hepatol Nutr. 2018;21(2):86-92.    doi: 10.5223/pghn.2018.21.2.86.


Reference

1. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001. 120:636–651.
Article
2. Catassi C, Fabiani E, Rätsch IM, Coppa GV, Giorgi PL, Pierdomenico R, et al. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr Suppl. 1996. 412:29–35.
Article
3. Hill I, Fasano A, Schwartz R, Counts D, Glock M, Horvath K. The prevalence of celiac disease in at-risk groups of children in the United States. J Pediatr. 2000. 136:86–90.
Article
4. Hoffenberg EJ, MacKenzie T, Barriga KJ, Eisenbarth GS, Bao F, Haas JE, et al. A prospective study of the incidence of childhood celiac disease. J Pediatr. 2003. 143:308–314.
Article
5. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. A multicenter study on the sero-prevalence of coeliac disease in the United States among both at risk and not at risk groups. Arch Int Med. 2003. 163:286–292.
6. Mäki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, et al. Prevalence of Celiac disease among children in Finland. N Engl J Med. 2003. 348:2517–2524.
Article
7. Catassi C, Fasano A. New developments in childhood celiac disease. Curr Gastroenterol Rep. 2002. 4:238–243.
8. Fasano A, Catassi C. Celiac disease in children. Best Pract Res Clin Gastroenterol. 2005. 19:467–478.
9. Kagnoff MF. Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest. 2007. 117:41–49.
Article
10. Demir H, Yüce A, Koçak N, Ozen H, Gürakan F. Celiac disease in Turkish children: presentation of 104 cases. Pediatr Int. 2000. 42:483–487.
Article
11. Ertekin V, Selimoğlu MA, Kardaş F, Aktaş E. Prevalence of celiac disease in Turkish children. J Clin Gastroenterol. 2005. 39:689–691.
Article
12. Masjedizadeh R, Hajiani E, Hashemi J, Shayesteh AA, Moula K, Rajabi T. Celiac disease in South-West of Iran. World J Gastroenterol. 2006. 12:4416–4419.
13. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child. 1990. 65:909–911.
14. McOmber ME, Shulman RJ. Recurrent abdominal pain and irritable bowel syndrome in children. Curr Opin Pediatr. 2007. 19:581–585.
Article
15. Boccia G, Manguso F, Coccorullo P, Masi P, Pensabene L, Staiano A. Functional defecation disorders in children: PACCT criteria versus Rome II criteria. J Pediatr. 2007. 151:394–398.e1.
Article
16. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity and weight velocity and stages of puberty. Arch Dis Child. 1976. 51:170–179.
Article
17. Barlow SE, Dietz WH. Obesity evaluation and treatment: Expret committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics. 1998. 102:E29.
18. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, et al. CDC growth charts: United States. Adv Data. 2000. 1–27.
19. Baroncelli GI, Bertelloni S, Sodini F, Saggese C. Osteoporosis in children and adolescents: etiology and management. Paediatr Drugs. 2005. 7:295–323.
20. Terasaki PI, Mcclelland JD. Microdroplet assay of human serum cytotoxins. Nature. 1964. 204:998–1000.
Article
21. Green PH, Jabri B. Coeliac disease. Lancet. 2003. 362:383–391.
Article
22. Mearin ML. Celiac disease among children and adolescents. Curr Probl Pediatr Adolesc Health Care. 2007. 37:86–105.
Article
23. Iughetti L, Bulgarelli S, Forese S, Lorini R, Balli F, Bernasconi S. Endocrine aspects of coeliac disease. J Pediatr Endocrinol Metab. 2003. 16:805–818.
Article
24. van Rijn JC, Grote FK, Oostdijk W, Wit JM. Short stature and the probability of coeliac disease, in the absence of gastrointestinal symptoms. Arch Dis Child. 2004. 89:882–883.
Article
25. Carroccio A, Iannitto E, Cavataio F, Montalto G, Tumminello M, Campagna P, et al. Sideropenic anemia and celiac disease: one study, two points of view. Dig Dis Sci. 1998. 43:673–678.
26. Bonamico M, Vania A, Monti S, Ballati G, Mariani P, Pitzalis G, et al. Iron deficiency in children with celiac disease. J Pediatr Gastroenterol Nutr. 1987. 6:702–706.
Article
27. Rossi E. Monosymptomatic forms of celiac disease. Eur J Pediatr. 1982. 138:4–5.
Article
28. Kalayci AG, Kanber Y, Birinci A, Yildiz L, Albayrak D. The prevalence of coeliac disease as detected by screening in children with iron deficiency anaemia. Acta Paediatr. 2005. 94:678–681.
Article
29. Catassi C, Fabiani E. The spectrum of coeliac disease in children. Baillieres Clin Gastroenterol. 1997. 11:485–507.
30. Leonardi S, Bottaro G, Patané R, Musumeci S. Hypertransaminasemia as the first symptom in infant celiac disease. J Pediatr Gastroenterol Nutr. 1990. 11:404–406.
31. Maggiore G, Caprai S. Liver involvement in celiac disease. Indian J Pediatr. 2006. 73:809–811.
32. Shamir R. Advances in celiac disease. Gastroenterol Clin North Am. 2003. 32:931–947.
33. Cavallaro R, Iovino P, Castiglione F, Palumbo A, Marino M, Di Bella S, et al. Prevalence and clinical associations of prolonged prothrombin time in adult untreated coeliac disease. Eur J Gastroenterol Hepatol. 2004. 16:219–223.
Article
34. Cavallaro R, Iovino P, Castiglione F, Palumbo A, Marino M, Di Bella S, et al. Prevalence and clinical associations of prolonged prothrombin time in adult untreated coeliac disease. Eur J Gastroenterol Hepatol. 2004. 16:219–223.
Article
35. Cataldo F, Marino V, Ventura A, Bottaro G, Corazza GR. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP) and "Club del Tenue" Working Groups on Coeliac Disease. Gut. 1998. 42:362–365.
Article
36. Hervonen K, Hakanen M, Kaukinen K, Collin P, Reunala T. First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis. Scand J Gastroenterol. 2002. 37:51–55.
Article
37. Lemberg D, Day AS, Bohane T. Coeliac disease presenting as dermatitis herpetiformis in infancy. J Paediatr Child Health. 2005. 41:294–296.
Article
38. Ertekin V, Selimoglu MA, Gursan N, Ozkan B. Idiopathic pulmonary hemosiderosis in children with celiac disease. Respir Med. 2006. 100:568–569.
Article
39. Kuloğlu Z, Kansu A, Tutar E, Yalçinkaya F, Ensari A, Girgin N. Association of familial Mediterranean fever and celiac disease in a 14-year-old girl with recurrent arthritis. Clin Exp Rheumatol. 2008. 26:S131.
40. Sategna Guidetti C, Solerio E, Scaglione N, Aimo G, Mengozzi G. Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut. 2001. 49:502–505.
Article
41. Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA. 2003. 290:1721–1728.
42. Ventura A, Magazzù G, Greco L. SIGED Study Group for Autoimmune Disorders in Celiac Disease. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology. 1999. 117:297–303.
43. Kumar V, Rajadhyaksha M, Wortsman J. Celiac disease-associated autoimmune endocrinopathies. Clin Diagn Lab Immunol. 2001. 8:678–685.
44. Mora G, Barera G, Beccio S, Menni L, Proverbio MC, Bianchi C, et al. A prospective, longitudinal study of the long-term effect of treatment on bone density in children with celiac disease. J Pediatr. 2001. 139:516–521.
45. Barera G, Mora S, Brambilla P, Ricotti A, Menni L, Beccio S, et al. Body composition in children with celiac disease and the effects of a gluten-free diet: a prospective case-control study. Am J Clin Nutr. 2000. 72:71–75.
46. Lunt H, Florkowski CM, Cook HB, Whitehead MR. Bone mineral density, type 1 diabetes, and celiac disease. Diabetes Care. 2001. 24:791–792.
Article
47. Tau C, Mautalen C, De Rosa S, Roca A, Valenzuela X. Bone mineral density in children with celiac disease. Effect of a Glutenfree diet. Eur J Clin Nutr. 2006. 60:358–363.
Article
48. Kalayci AG, Kansu A, Girgin N, Kucuk O, Aras G. Bone mineral density and importance of a gluten-free diet in patients with celiac disease in childhood. Pediatrics. 2001. 108:E89.
Article
49. Gobbi G, Bouquet F, Greco L, Lambertini A, Tassinari CA, Ventura A, et al. Coeliac disease, epilepsy, and cerebral calcifications. The Italian Working Group on Coeliac Disease and Epilepsy. Lancet. 1992. 340:439–443.
50. Bushara KO. Neurologic presentation of celiac disease. Gastroenterology. 2005. 128:S92–S97.
Article
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr